Zylox-Tonbridge Medical Technology Co., Ltd. (FRA:818)

Market Cap	838.26M +95.3%
Revenue (ttm)	106.79M +35.4%
Net Income	18.14M +495.0%
EPS	0.06 +495.2%
Shares Out	n/a
PE Ratio	46.22
Forward PE	29.37
Dividend	0.01 (0.51%)
Ex-Dividend Date	Jun 4, 2025

Volume	n/a
Average Volume	91
Open	2.380
Previous Close	n/a
Day's Range	2.380 - 2.380
52-Week Range	1.370 - 2.980
Beta	n/a
RSI	38.49
Earnings Date	Mar 20, 2026

About FRA:818

Zylox-Tonbridge Medical Technology Co., Ltd., a medical device company, provides neuro- and peripheral-vascular interventional medical devices in the People’s Republic of China and internationally. The company offers a neurovascular product portfolio that covers a suite of products for various categories, including ischemic stroke, hemorrhagic stroke, intracranial stenosis, carotid artery, and intracranial access devices. Its peripheral-vascular interventional product portfolio includes stents, balloons, catheters, and filters, as well as cover...

• Industry: Surgical and Medical Instruments and Apparatus
• Founded: 2012
• Employees: 875
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 818

Financial Performance

Financial numbers in CNY